Literature DB >> 25960714

Monitoring of hematopoietic chimerism by real-time quantitative PCR of micro insertions/deletions in samples with low DNA quantities.

Christian Bach1, Elmira Tomova1, Katja Goldmann1, Volker Weisbach2, Wolf Roesler1, Andreas Mackensen1, Julia Winkler1, Bernd M Spriewald1.   

Abstract

BACKGROUND: Sensitive and accurate methods to detect hematopoietic chimerism after hematopoietic stem cell transplantation (HSCT) are essential to evaluate engraftment and to monitor response to therapeutic procedures such as donor lymphocyte infusion. Continuous long-term follow up, however, requires large amounts of pre-HSCT samples limiting the application of many widely used techniques for sensitive chimerism monitoring.
METHODS: DNAs from 42 normal healthy donors and 16 HSCT donor/recipient pairs were employed to validate the use of allele-specific insertion/deletion (indel) quantitative real-time polymerase chain reaction (qPCR) to quantify chimerism in samples with low amounts of DNA. Consequently, indel-qPCR analyses of samples from 16 HSCT patients were compared to short-tandem repeat (STR) specific PCR analyses.
RESULTS: Typing with reduced amounts of input DNA (15 vs. 60 ng) allowed for the reliable distinction of positive (mean threshold cycle (ct) 28.05) and negative (ct >36) signals. The high informativity of primer/probe sets, with 12 out of 19 markers exceeding 20% informativity, was confirmed in our cohort (n = 74). Importantly, a fourfold reduction of input DNA compared to published protocols did not alter PCR efficiencies and allowed for a more sensitive detection of chimerism in 7 of 16 HSCT patients compared to results obtained by STR-PCR.
CONCLUSIONS: Our data suggest that indel-qPCR is a more sensitive technique for the detection of hematopoietic chimerism compared to STR-PCR and works efficiently for samples with low amounts of DNA.

Entities:  

Keywords:  Chimerism; Molecular diagnostic techniques; Quantitative real-time polymerase chain reaction; Stem cell transplantation

Year:  2014        PMID: 25960714      PMCID: PMC4404891          DOI: 10.1159/000370255

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  36 in total

Review 1.  Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris-Robert Debré experience.

Authors:  C Acquaviva; M Duval; D Mirebeau; R Bertin; H Cavé
Journal:  Leukemia       Date:  2003-01       Impact factor: 11.528

2.  Evaluation of the sensitivity of two recently developed STR multiplexes for the analysis of chimerism after haematopoietic stem cell transplantation.

Authors:  A Odriozola; J A Riancho; M Colorado; M T Zarrabeitia
Journal:  Int J Immunogenet       Date:  2012-05-18       Impact factor: 1.466

3.  Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse.

Authors:  O Horky; J Mayer; L Kablaskova; F Razga; M Krejci; J Kissova; M Borsky; I Jeziskova; D Dvorakova
Journal:  Int J Lab Hematol       Date:  2011-02       Impact factor: 2.877

4.  Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction.

Authors:  Mehdi Alizadeh; Marc Bernard; Bruno Danic; Charly Dauriac; Brigitte Birebent; Christine Lapart; Thierry Lamy; Pierre-Yves Le Prisé; Alain Beauplet; Dominique Bories; Gilbert Semana; Erwann Quelvennec
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

5.  High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).

Authors:  M R Baer; C C Stewart; R K Dodge; G Leget; N Sulé; K Mrózek; C A Schiffer; B L Powell; J E Kolitz; J O Moore; R M Stone; F R Davey; A J Carroll; R A Larson; C D Bloomfield
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

6.  Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse.

Authors:  J E van Leeuwen; M J van Tol; A M Joosten; J T Wijnen; P M Khan; J M Vossen
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

7.  Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.

Authors:  Manuel Barrios; Antonio Jiménez-Velasco; José Román-Gómez; María Elena Madrigal; Juan Antonio Castillejo; Antonio Torres; Anabel Heiniger
Journal:  Haematologica       Date:  2003-07       Impact factor: 9.941

8.  Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.

Authors:  R S Hill; F B Petersen; R Storb; F R Appelbaum; K Doney; S Dahlberg; R Ramberg; E D Thomas
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

9.  A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.

Authors:  Ephraim P Hochberg; David B Miklos; Donna Neuberg; Daniel A Eichner; Stephen F McLaughlin; Alex Mattes-Ritz; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2002-08-29       Impact factor: 22.113

10.  Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium.

Authors:  D C Roy; R Tantravahi; C Murray; K Dear; B Gorgone; K C Anderson; A S Freedman; L M Nadler; J Ritz
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

View more
  6 in total

1.  HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients.

Authors:  Ruonan Xu; Ji-Yuan Zhang; Bo Tu; Zhe Xu; Hui-Huang Huang; Lei Huang; Yan-Mei Jiao; Tao Yang; Chao Zhang; En-Qiang Qin; Tian-Jun Jiang; Yun-Bo Xie; Yuan-Yuan Li; Lei Jin; Chun-Bao Zhou; Ming Shi; Mei Guo; Hui-Sheng Ai; Linqi Zhang; Fu-Sheng Wang
Journal:  Signal Transduct Target Ther       Date:  2021-05-07

2.  Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms.

Authors:  Jennifer Valero-Garcia; María Del Carmen González-Espinosa; Manuel Barrios; Greta Carmona-Antoñanzas; Javier García-Planells; Carlos Ruiz-Lafora; Ainhoa Fuentes-Gálvez; Antonio Jiménez-Velasco
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

3.  Donor Chimerism Study by Single Nucleotide Polymorphism using SYBR green based Real Time PCR.

Authors:  Ayesha Nayyar; Suhaib Ahmed
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

Review 4.  Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation.

Authors:  Hajnalka Andrikovics; Zoltán Őrfi; Nóra Meggyesi; András Bors; Lívia Varga; Petra Kövy; Zsófia Vilimszky; Fanni Kolics; László Gopcsa; Péter Reményi; Attila Tordai
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

5.  Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application.

Authors:  Almudena Navarro-Bailón; Diego Carbonell; Asunción Escudero; María Chicano; Paula Muñiz; Julia Suárez-González; Rebeca Bailén; Gillen Oarbeascoa; Mi Kwon; José Luis Díez-Martín; Carolina Martínez-Laperche; Ismael Buño
Journal:  Genes (Basel)       Date:  2020-08-25       Impact factor: 4.096

Review 6.  Chimerism Monitoring Techniques after Hematopoietic Stem Cell Transplantation: An Overview of the Last 15 Years of Innovations.

Authors:  Pamela Tozzo; Arianna Delicati; Renato Zambello; Luciana Caenazzo
Journal:  Diagnostics (Basel)       Date:  2021-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.